Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Cardiac-specific overexpression of GTP cyclohydrolase 1 restores ischaemic preconditioning during hyperglycaemia.

Ge ZD, Ionova IA, Vladic N, Pravdic D, Hirata N, Vásquez-Vivar J, Pratt PF Jr, Warltier DC, Pieper GM, Kersten JR.

Cardiovasc Res. 2011 Jul 15;91(2):340-9. doi: 10.1093/cvr/cvr079. Epub 2011 Mar 21.

2.

Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning.

Vladic N, Ge ZD, Leucker T, Brzezinska AK, Du JH, Shi Y, Warltier DC, Pratt PF Jr, Kersten JR.

Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H2130-9. doi: 10.1152/ajpheart.01078.2010. Epub 2011 Sep 9.

3.

Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.

Shimazu T, Otani H, Yoshioka K, Fujita M, Okazaki T, Iwasaka T.

Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H2061-72. doi: 10.1152/ajpheart.00525.2011. Epub 2011 Sep 2.

PMID:
21890687
4.

Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1.

Shinmura K, Tamaki K, Bolli R.

Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2348-55. doi: 10.1152/ajpheart.00602.2008. Epub 2008 Oct 17.

5.
6.

GTP cyclohydrolase I phosphorylation and interaction with GTP cyclohydrolase feedback regulatory protein provide novel regulation of endothelial tetrahydrobiopterin and nitric oxide.

Li L, Rezvan A, Salerno JC, Husain A, Kwon K, Jo H, Harrison DG, Chen W.

Circ Res. 2010 Feb 5;106(2):328-36. doi: 10.1161/CIRCRESAHA.109.210658. Epub 2009 Nov 19.

7.

Cardioprotective PKG-independent NO signaling at reperfusion.

Cohen MV, Yang XM, Liu Y, Solenkova NV, Downey JM.

Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H2028-36. doi: 10.1152/ajpheart.00527.2010. Epub 2010 Sep 17.

8.

Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.

Booij HG, Yu H, De Boer RA, van de Kolk CW, van de Sluis B, Van Deursen JM, Van Gilst WH, Silljé HH, Westenbrink BD.

Cardiovasc Res. 2016 Aug 1;111(3):217-26. doi: 10.1093/cvr/cvw161. Epub 2016 Jun 14.

PMID:
27302402
9.

eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex.

Talukder MA, Yang F, Shimokawa H, Zweier JL.

Am J Physiol Heart Circ Physiol. 2010 Aug;299(2):H437-45. doi: 10.1152/ajpheart.00384.2010. Epub 2010 Jun 4.

10.

Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation.

Yang C, Talukder MA, Varadharaj S, Velayutham M, Zweier JL.

Cardiovasc Res. 2013 Jan 1;97(1):33-43. doi: 10.1093/cvr/cvs287. Epub 2012 Sep 12.

11.

Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.

Sánchez JA, Rodríguez-Sinovas A, Barba I, Miró-Casas E, Fernández-Sanz C, Ruiz-Meana M, Alburquerque-Béjar JJ, García-Dorado D.

Basic Res Cardiol. 2013 May;108(3):351. doi: 10.1007/s00395-013-0351-3. Epub 2013 Apr 18.

PMID:
23595215
12.

Apolipoprotein A-1 mimetic D-4F enhances isoflurane-induced eNOS signaling and cardioprotection during acute hyperglycemia.

Baotic I, Ge ZD, Sedlic F, Coon A, Weihrauch D, Warltier DC, Kersten JR.

Am J Physiol Heart Circ Physiol. 2013 Jul 15;305(2):H219-27. doi: 10.1152/ajpheart.00850.2012. Epub 2013 May 10.

13.

Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.

Moolman JA, Hartley S, Van Wyk J, Marais E, Lochner A.

Cardiovasc Drugs Ther. 2006 Feb;20(1):13-25.

PMID:
16552474
14.

Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.

Faghihi M, Mirershadi F, Dehpour AR, Bazargan M.

Eur J Pharmacol. 2008 Nov 12;597(1-3):57-63. doi: 10.1016/j.ejphar.2008.08.010. Epub 2008 Aug 22.

PMID:
18789320
15.

Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.

Gonon AT, Widegren U, Bulhak A, Salehzadeh F, Persson J, Sjöquist PO, Pernow J.

Cardiovasc Res. 2008 Apr 1;78(1):116-22. doi: 10.1093/cvr/cvn017. Epub 2008 Jan 25.

PMID:
18222959
16.

Cardiac myocyte-specific overexpression of human GTP cyclohydrolase I protects against acute cardiac allograft rejection.

Ionova IA, Vásquez-Vivar J, Cooley BC, Khanna AK, Whitsett J, Herrnreiter A, Migrino RQ, Ge ZD, Regner KR, Channon KM, Alp NJ, Pieper GM.

Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H88-96. doi: 10.1152/ajpheart.00203.2010. Epub 2010 Apr 23.

17.

Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.

du Toit EF, Genade S, Carlini S, Moolman JA, Brunner F, Lochner A.

Eur J Pharmacol. 2007 Feb 5;556(1-3):115-20. Epub 2006 Nov 10.

PMID:
17157294
18.

Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling.

Liu Y, Jin J, Qiao S, Lei S, Liao S, Ge ZD, Li H, Wong GT, Irwin MG, Xia Z.

Clin Sci (Lond). 2015 Aug;129(4):331-44. doi: 10.1042/CS20140789.

PMID:
25849791
19.

A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70.

Yin C, Salloum FN, Kukreja RC.

Circ Res. 2009 Mar 13;104(5):572-5. doi: 10.1161/CIRCRESAHA.108.193250. Epub 2009 Feb 12.

20.

Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection.

Støttrup NB, Løfgren B, Birkler RD, Nielsen JM, Wang L, Caldarone CA, Kristiansen SB, Contractor H, Johannsen M, Bøtker HE, Nielsen TT.

Cardiovasc Res. 2010 Nov 1;88(2):257-66. doi: 10.1093/cvr/cvq205. Epub 2010 Jun 18.

PMID:
20562422

Supplemental Content

Support Center